Advertisement

Iron Metabolism and Iron Deficiency Anemia

  • Meera Sikka
  • Harresh B. Kumar
Chapter

Abstract

Nutritional deficiencies are the most common cause of anemia. Deficiency of iron is the most common micronutrient deficiency with several adverse consequences. In this chapter, we discuss normal iron metabolism, etiopathogenesis, and laboratory tests along with prevention and treatment of iron deficiency anemia. Functional iron deficiency and iron deficiency anemia coexistent with thalassemia trait are also discussed.

Keywords

Iron deficiency Ferritin Transferrin receptor Hepcidin 

References

  1. 1.
    Winter WE, Bazydlo LA, Harris NS. The molecular biology of human iron metabolism. Medicine. 2014;45:92–102.Google Scholar
  2. 2.
    Barragan-Ibanez G, Santoyo-Sanchez A, Ramos-Penafiel CO. Iron deficiency anemia. Rev Med Hosp Gen Mex. 2016;79:41–114.  https://doi.org/10.1016/j.hgmx.2015.06.008.CrossRefGoogle Scholar
  3. 3.
    Andrews NC. Iron deficiency and related disorders. In: Greer JP, Foerster J, Rodgers GM, Paraskevas F, Glader B, Arber DA, Means RT, editors. Wintrobe’s clinical hematology. 12th ed. Philadelphia: Lippincott Williams and Wilkins; 2009. p. 810–34.Google Scholar
  4. 4.
    Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anaemia. Lancet. 2016;387(10021):907–16.CrossRefGoogle Scholar
  5. 5.
    DeLoughery TG. Iron deficiency anemia. Med Clin North Am. 2017;101:319–32.CrossRefGoogle Scholar
  6. 6.
    Tandara L, Salamunic I. Iron metabolism: current facts and future directions. Biochem Med. 2012;22:311–28.CrossRefGoogle Scholar
  7. 7.
    Wang J, Pantopoulos K. Regulation of cellular iron metabolism. Biochem J. 2011;434:365–81.CrossRefGoogle Scholar
  8. 8.
    Punnonen K, Rajamaki A. Serum transferrin receptor and it’s ratio to serum ferritin in the diagnosis of iron deficiency. Blood. 1997;89:1052–7.PubMedGoogle Scholar
  9. 9.
    Silva B, Faustino P. An overview of molecular basis of iron metabolism regulation and the associated pathologies. Biochim Biophys Acta. 2015;1852:1347–59.CrossRefGoogle Scholar
  10. 10.
    Zhao N, Zhang A, Enns CA. Iron regulation by hepcidin. J Clin Invest. 2013;123:2337–43.CrossRefGoogle Scholar
  11. 11.
    Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta. 2012;1823:1434–43.CrossRefGoogle Scholar
  12. 12.
    Muckenthaler MU, Rivella S, Hentze MW, Galy B. A red carpet for iron metabolism. Cell. 2017;168:344–58.CrossRefGoogle Scholar
  13. 13.
    De Benoist B, McLean E, Egil I, Cogswell M. Worldwide prevalence of anaemia 1993–2005. WHO global database on anaemia. Geneva: WHO; 2008.Google Scholar
  14. 14.
    DeMaeyer EM, AdielsTegman M. The prevalence of anemia in the world. World Health Stat Q. 1985;38:302–16.PubMedGoogle Scholar
  15. 15.
    WHO. Iron deficiency anemia assessment, prevention and control: a guide for programme managers. Geneva: World Health Organization; 2001.Google Scholar
  16. 16.
    Madan N, Rusia U, Sikka M, Sharma S, Shankar N. Developmental and neurophysiologic deficits in iron deficiency in children. Indian J Pediatr. 2011;78:58–64.CrossRefGoogle Scholar
  17. 17.
    Falkingham M, Abdelhamid A, Curtis P, Fairweather-Tait S, Dye L, Hooper L. The effects of oral iron supplementation on cognition in older children and adults: a systematic review and meta-analysis. Nutr J. 2010;9:4–10.CrossRefGoogle Scholar
  18. 18.
    Stoltzfus RM, Mullany L, Black RE. Iron deficiency anaemia. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors, vol. 1. Geneva: World Health Organization; 2005. p. 163–209.Google Scholar
  19. 19.
    WHO. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization; 2009.Google Scholar
  20. 20.
    Charles CV. Iron deficiency anemia: a public health problem of global proportions. In: Maddock J, editor. Public health—methodology, environmental and systems issues. Rijeka: InTech; 2012. ISBN: 978-953-51-0641.Google Scholar
  21. 21.
    Buratti P, Gammella E, Rybinska I, Cairo G, Recalcati S. Recent advances in iron metabolism: relevance for health, exercise and performance. Med Sci Sports Exerc. 2015;47:1–8.CrossRefGoogle Scholar
  22. 22.
    Kassebaum NJ, Jasrasaria R, Naghavi M. A systematic analysis of global anemia burden from 1990-2010. Blood. 2013;123:615–24.CrossRefGoogle Scholar
  23. 23.
    Auerbach M, Adamson JW. How we diagnose and treat iron deficiency anemia. Am J Hematol. 2016;91:31–8.CrossRefGoogle Scholar
  24. 24.
    Brugnara C, Schiller B, Moran J. Reticulocyte hemoglobin equivalent (Ret-He) and assessment of iron deficient states. Clin Lab Haematol. 2006;28:303–8.CrossRefGoogle Scholar
  25. 25.
    Bovy C, Gothot A, Krzesinski JM, Beguin Y, Sart-Tilman CHU. Mature erythrocyte indices: new markers of iron availability. Hematologica. 2005;90:549–51.Google Scholar
  26. 26.
    Cappellini DM, Comin-Colet J, de Francisco A, Dignass A, Doehner W, Lam CSP, et al. Iron deficiency across chronic inflammatory conditions: international expert opinion on definition, diagnosis, and management on behalf of the IRON CORE Group. Am J Hematol. 2017;92:1068–78.CrossRefGoogle Scholar
  27. 27.
    Hallberg L, Bengtsson C, lapidus L, Lindstedt G, Hulten L. Screening for iron deficiency: an analysis based on bone marrow examinations and serum ferritin determinations in a population sample of women. Br J Haematol. 1993;85:787–98.CrossRefGoogle Scholar
  28. 28.
    Camaschella C. Iron deficiency anemia. N Engl J Med. 2015;372:1832–43.CrossRefGoogle Scholar
  29. 29.
    Pasricha SR, Drakesmith H. Iron deficiency anemia. Problems in diagnosis and prevention at the population level. Hematol Oncol Clin North Am. 2016;30:309–25.CrossRefGoogle Scholar
  30. 30.
    Skikne BS, Punnonen K, Caldron PH, Bennett MT, Rehu M, Gasior GH, Chamberlin JS, Sullivan LA, Bray KR, Southwick PC. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index. Am J Hematol. 2011;86:923–7.CrossRefGoogle Scholar
  31. 31.
    Suominen P, Punnonen K, Rajamaki A, Irjala K. Serum transferrin receptor and transferrin receptor-ferritin index identify healthy subjects with subclinical iron deficits. Blood. 1998;8:2934–9.Google Scholar
  32. 32.
    Franceschi LD, Iolascon A, Taher A, Cappellini MD. Clinical management of iron deficiency anemia in adults: systematic review on advances in diagnosis and treatment. Eur J Intern Med. 2017;42:16–23.  https://doi.org/10.1016/j.ejim.2017.04.018.CrossRefPubMedGoogle Scholar
  33. 33.
    Bregman DB, Goodnough LT. Experience with intravenous ferric carboxymaltose in patients with iron deficiency anemia. Ther Adv Hematol. 2014;5:48–60.CrossRefGoogle Scholar
  34. 34.
    Pasricha SR, Atkinson SH, Armitage AE, Khandwala S, Veenemans J, Cox SE, et al. Expression of the iron hormone hepcidin distinguishes different types of anemia in African children. Sci Transl Med. 2014;6:235re3.CrossRefGoogle Scholar
  35. 35.
    Mantadakis E, Roganovic J. Safety and efficacy of ferric carboxymaltose in children and adolescents with iron deficiency anemia. J Pediatr. 2017;184:241.CrossRefGoogle Scholar
  36. 36.
    Powers JM, Shamoun M, McCavit TL, Adix L, Buchanan GR. Intravenous ferric carboxymaltose in children with iron deficiency anemia who respond poorly to oral iron. J Pediatr. 2016;108:221–6.Google Scholar
  37. 37.
    Goddard AF, James MW, McIntyre AS, Scott BB, The British Society of Gastroenterology. Guidelines for the management of iron deficiency anaemia. Gut. 2011;60:1309–16.CrossRefGoogle Scholar
  38. 38.
    Okam MM, Koch TA, Tran MH. Iron deficiency anemia treatment response to oral iron therapy: a pooled analysis of five randomized controlled trials. Haematologica. 2016;101:e6–7.CrossRefGoogle Scholar
  39. 39.
    Prentice AM, Mendoza YA, Pereira D, Cerami C, Wegmuller R, Constable A, Spieldenner J. Dietary strategies for improving iron status: balancing safety and efficacy. Nutr Rev. 2016;75:49–60.CrossRefGoogle Scholar
  40. 40.
    WHO. Recommendations on wheat and maize flour fortification meeting report: interim. Geneva: World Health Organization; 2009.Google Scholar
  41. 41.
    Wish JB. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol. 2006;1:S4–8.CrossRefGoogle Scholar
  42. 42.
    Archer NM, Brugnara C. Diagnosis of iron-deficient states. Crit Rev Clin Lab Sci. 2015;52(5):256–72.CrossRefGoogle Scholar
  43. 43.
    Wayne Thomas D, Hinchliffe RF, Briggs C, Macdougall IC, Littlewood T, Cavill I. Guideline for the laboratory diagnosis of functional iron deficiency. Br J Haematol. 2013;161:639–48.CrossRefGoogle Scholar
  44. 44.
    Madan N, Sikka M, Sharma S, Rusia U. Serum ferritin levels in carriers of beta thalassemia trait. Acta Haematol. 1996;96:267.CrossRefGoogle Scholar
  45. 45.
    Bain BJ. The α, β, δ, and γ thalassaemias and related conditions. In: Bain BJ, editor. Hemoglobinopathy diagnosis. 2nd ed. Malden: Blackwell; 2006. p. 63–138.CrossRefGoogle Scholar
  46. 46.
    Batebi APA, Esmailian R. Discrimination of beta-thalassemia minor and iron deficiency anemia by screening test for red blood cell indices. Turk J Med Sci. 2012;42(2):275–80.Google Scholar
  47. 47.
    Rao S, Kar R, Gupta SK, Chopra A, Saxena R. Spectrum of hemoglobinopathies diagnosed by cation exchange-HPLC and modulating effects of nutritional deficiency anemias from North India. Indian J Med Res. 2010;132:513–9.PubMedPubMedCentralGoogle Scholar
  48. 48.
    Ryan K, Bain BJ, Worthington D, James J, Plews D, Mason A, Roper D, Rees DC, de la Salle B, Streetly A, British Committee for Standards in Haematology. Significant haemoglobinopathies: guidelines for screening and diagnosis. Br J Haematol. 2010;149(1):35–49.CrossRefGoogle Scholar
  49. 49.
    Madan N, Sikka M, Sharma S, Rusia U. Phenotypic expression of HbA2 in beta thalassemia trait with iron deficiency. Ann Hematol. 1998;77:93–6.CrossRefGoogle Scholar
  50. 50.
    Higgs DR. The pathophysiology and clinical features of α thalassaemia. In: Steinberg MH, Forget BG, Higgs DR, Weatherall DJ, editors. Disorders of hemoglobin: genetics, pathophysiology, and clinical management. 2nd ed. New York: Cambridge University Press; 2009. p. 266–95.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Meera Sikka
    • 1
  • Harresh B. Kumar
    • 1
  1. 1.Department of PathologyUCMS and GTB HospitalDelhiIndia

Personalised recommendations